Galena Biopharma to Present at the Piper Jaffray 24th Annual Healthcare Conference LAKE OSWEGO, Ore., Nov. 20, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and CEO, will present a corporate overview at the Piper Jaffray 24^th Annual Healthcare Conference. The presentation will take place on Tuesday, November 27, 2012 at 2:30 p.m. EST at The New York Palace Hotel in New York, NY. About Galena Biopharma Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com. The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647 CONTACT: Madeline Hatton Toll free: +1 (855) 855-GALE (4253), ext. 109 firstname.lastname@example.org or Remy Bernarda IR Sense, LLC +1 (503) 400-6995 email@example.com Galena Biopharma, Inc.
Dupont Posts Fourth-Quarter Operating EPS of 71c, Meeting Estimates
Galena Biopharma to Present at the Piper Jaffray 24th Annual Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.